DT-9081 Study in Participants With Advanced, Recurrent or Metastatic Solid Tumours

NCT05582850 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
29
Enrollment
INDUSTRY
Sponsor class

Stopped The trial was terminated prematurely at the end of the dose-escalation based on Sponsor's strategic decision.

Conditions

Interventions

Sponsor

Domain Therapeutics SA